160 related articles for article (PubMed ID: 15143480)
1. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
2. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.
Ng EK; Panesar N; Longo WE; Shapiro MJ; Kaminski DL; Tolman KC; Mazuski JE
Mediators Inflamm; 2003 Feb; 12(1):3-8. PubMed ID: 12745542
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile toxin A stimulates macrophage-inflammatory protein-2 production in rat intestinal epithelial cells.
Castagliuolo I; Keates AC; Wang CC; Pasha A; Valenick L; Kelly CP; Nikulasson ST; LaMont JT; Pothoulakis C
J Immunol; 1998 Jun; 160(12):6039-45. PubMed ID: 9637520
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
6. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.
Mahida YR; Makh S; Hyde S; Gray T; Borriello SP
Gut; 1996 Mar; 38(3):337-47. PubMed ID: 8675084
[TBL] [Abstract][Full Text] [Related]
7. Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion.
Tixier E; Lalanne F; Just I; Galmiche JP; Neunlist M
Cell Microbiol; 2005 Dec; 7(12):1798-810. PubMed ID: 16309465
[TBL] [Abstract][Full Text] [Related]
8. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
9. NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A.
Kim JM; Lee JY; Yoon YM; Oh YK; Youn J; Kim YJ
Scand J Immunol; 2006 Jun; 63(6):453-60. PubMed ID: 16764699
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxins and enterococcal translocation in vivo and in vitro.
Feltis BA; Garni RM; Wells CL
J Surg Res; 2001 May; 97(1):97-102. PubMed ID: 11319888
[TBL] [Abstract][Full Text] [Related]
11. Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine.
Planchon SM; Martins CA; Guerrant RL; Roche JK
J Immunol; 1994 Dec; 153(12):5730-9. PubMed ID: 7989770
[TBL] [Abstract][Full Text] [Related]
12. Effect of host defenses on Clostridium difficile toxin-induced intestinal barrier injury.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2013 Apr; 74(4):983-89; discussion 989-90. PubMed ID: 23511135
[TBL] [Abstract][Full Text] [Related]
13. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
Salib RJ; Lau LC; Howarth PH
Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
15. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
16. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
17. [Response of the IRD intestinal epithelial cell line to Clostridium difficile toxins A and B in rats. Effect of Saccharomyces boulardii].
Czerucka D; Nano JL; Bernasconi P; Rampal P
Gastroenterol Clin Biol; 1991; 15(1):22-7. PubMed ID: 1849105
[TBL] [Abstract][Full Text] [Related]
18. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
[TBL] [Abstract][Full Text] [Related]
19. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of Clostridium difficile toxins on hepatocytes.
Mazuski JE; Panesar N; Tolman K; Longo WE
J Surg Res; 1998 Oct; 79(2):170-8. PubMed ID: 9758734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
